We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+32.2%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
+$1.12B
(+80%)
Cap. Flow
+$772M
Cap. Flow
% of AUM
30.59%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
205
New
69
Increased
52
Reduced
26
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$62.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$61M |
| 3 |
Fidelity National Information Services
FIS
|
+$54.2M |
| 4 |
KLA
KLAC
|
+$44.1M |
| 5 |
PayPal
PYPL
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$65.7M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$46.8M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$46.5M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$41.2M |
| 5 |
Analog Devices
ADI
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.91% |
| 2 | Technology | 35.52% |
| 3 | Communication Services | 5.66% |
| 4 | Consumer Discretionary | 4.26% |
| 5 | Industrials | 2.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Amazon
AMZN
$2.92T
| – | – |
-93,380
| Closed | -$9.1M |
|
152
Arista Networks
ANET
$227B
| – | – |
-325,776
| Closed | -$4.12M |
|
|
APLS
153
DELISTED
Apellis Pharmaceuticals
APLS
| – | – |
-224,948
| Closed | -$6.03M |
|
154
Baxter International
BAX
$13.5B
| – | – |
-252,032
| Closed | -$20.5M |
|
155
BioMarin Pharmaceuticals
BMRN
$11.6B
| – | – |
-134,149
| Closed | -$11.3M |
|
156
Charter Communications
CHTR
$17.3B
| – | – |
-33,664
| Closed | -$14.7M |
|
157
Ciena
CIEN
$53.4B
| – | – |
-128,405
| Closed | -$5.11M |
|
158
Coherent
COHR
$51.4B
| – | – |
-53,426
| Closed | -$1.52M |
|
159
DaVita
DVA
$15.4B
| – | – |
-121,157
| Closed | -$9.21M |
|
160
Euronet Worldwide
EEFT
$2.72B
| – | – |
-89,667
| Closed | -$7.69M |
|
161
Elevance Health
ELV
$81.5B
| – | – |
-37,048
| Closed | -$8.41M |
|
162
Edwards Lifesciences
EW
$49.6B
| – | – |
-172,383
| Closed | -$10.8M |
|
|
FISV
163
Fiserv Inc
FISV
$28.8B
| – | – |
-214,400
| Closed | -$20.4M |
|
|
164
Alphabet (Google) Class A
GOOGL
$4.36T
| – | – |
-800,620
| Closed | -$46.5M |
|
165
HCA Healthcare
HCA
$87.2B
| – | – |
-39,718
| Closed | -$3.57M |
|
|
HUYA
166
Huya Inc
HUYA
$563M
| – | – |
-421,821
| Closed | -$7.15M |
|
167
Iovance Biotherapeutics
IOVA
$1.82B
| – | – |
-280,498
| Closed | -$8.4M |
|
168
Jabil
JBL
$33B
| – | – |
-153,821
| Closed | -$3.78M |
|
169
JD.com
JD
$44.6B
| – | – |
-150,226
| Closed | -$6.08M |
|
170
Ligand Pharmaceuticals
LGND
$5.76B
| – | – |
-32,932
| Closed | -$1.49M |
|
171
Live Nation Entertainment
LYV
$40.6B
| – | – |
-51,924
| Closed | -$2.36M |
|
172
Microchip Technology
MCHP
$40.3B
| – | – |
-13,994
| Closed | -$474K |
|
173
Mercado Libre
MELI
$95.2B
| – | – |
-4,208
| Closed | -$2.06M |
|
174
Molina Healthcare
MOH
$10.2B
| – | – |
-68,276
| Closed | -$9.54M |
|
175
Marvell Technology
MRVL
$168B
| – | – |
-906,665
| Closed | -$20.5M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Woodline Partners held 205 positions worth $2.52B, up 80% from $1.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Woodline Partners deployed $772M of net new capital in Q2 2020, opening 69 new positions and adding to 52 existing holdings. Its largest new stake was Johnson & Johnson: 418,880 shares worth $58.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 46% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $41.2M trimmed.
- Woodline Partners's largest Q2 2020 buy was Johnson & Johnson: 418,880 shares worth $58.9M.
- Woodline Partners added most to Intel in Q2 2020, an estimated $62.5M increase.
- Woodline Partners's biggest Q2 2020 reduction was Immunomedics Inc, cutting an estimated $41.2M.
- Woodline Partners fully exited Pfizer in Q2 2020, selling an estimated $65.7M.
- Woodline Partners's ten largest holdings make up 26% of its $2.52B portfolio in Q2 2020.
- Woodline Partners opened 69 new positions and closed 58 in Q2 2020.
- Woodline Partners's portfolio value rose 80% quarter-over-quarter to $2.52B.
Based on Woodline Partners's 13F filing for Q2 2020, filed 14 Aug 2020.